Clinical Trials Directory

Immune Function in Acute Kidney Injury

The North Sea Race Endurance Exercise Study

Rituximab, Lenalidomide, and Ibrutinib in Treating Patients With Previously Untreated Stage II-IV Follicular Lymphoma

Gene Therapy for X-linked Chronic Granulomatous Disease (X-CGD)

A Clinical and Molecular Risk-Directed Therapy for Newly Diagnosed Medulloblastoma

Protocol for the Study and Treatment of Participants With Intraocular Retinoblastoma

Phase I Trial of VS-6766 Alone and in Combination With Everolimus

The Role of Lifestyle Factors in Breast Cancer-Related Outcomes

A Study to Evaluate Genetic Predictors of Aromatase Inhibitor Musculoskeletal Symptoms (AIMSS)

Studying the Physical Function and Quality of Life Before and After Surgery in Patients With Stage I Cervical Cancer

CD34+ (Malignant) Stem Cell Selection for Patients Receiving Allogenic Stem Cell Transplant

Technical Development for Pediatric Cardiovascular MRI

Chemotherapy and Maximal Tumor Debulking of Multi-organ Colorectal Cancer Metastases

Parental Decision-Making for Children With Relapsed Neuroblastoma

Irinotecan and Temozolomide in Combination With Existing High Dose Alkylator Based Chemotherapy for Treatment of Patients With Newly Diagnosed Ewing Sarcoma

Technology Intensified Diabetes Education Study in African Americans

Brentuximab Vedotin Combined With AVD Chemotherapy in Patients With Newly Diagnosed Early Stage, Unfavorable Risk Hodgkin Lymphoma

Meta-Analyses of the Effect of Plant Protein Versus Animal Protein on Cardiometabolic Risk

T-Lymphocytes Genetically Targeted to the B-Cell Specific Antigen CD19 in Pediatric and Young Adult Patients With Relapsed B-Cell Acute Lymphoblastic Leukemia

Non-Myeloablative Conditioning and Bone Marrow Transplantation

T-DM1 vs Paclitaxel/Trastuzumab for Breast (ATEMPT Trial)

Gene Expression in Patients With Metastatic Prostate Cancer Receiving CYP-17 Inhibition Therapy

Randomized Controlled Trial of Shunt vs ETV/CPC for PIH in Ugandan Infants

An Efficacy and Safety Study of HGT-1110 in Participants With Metachromatic Leukodystrophy

Radiation and Androgen Ablation for Prostate Cancer

Randomized, Double-blind Study Comparing Tremelimumab to Placebo in Subjects With Unresectable Malignant Mesothelioma

The Ma'Anshan Birth Cohort (MABC)

Technology to Assess Vulnerable Older Adults With Cancer and Their Caregivers

Differentiated Thyroid Cancer: is There a Need for Radioiodine Ablation in Low Risk Patients?

STRONG Kids 2: A Cells-to-Society Approach to Nutrition in Early Childhood

Evaluation of the Efficacy of Intramuscular Islet Autograft After Extensive Pancreatectomy

Ibrutinib in Treating Patients With Relapsed Hairy Cell Leukemia

High Dose Therapy and Autologous Stem Cell Transplantation Followed by Infusion of Chimeric Antigen Receptor (CAR) Modified T-Cells Directed Against CD19+ B-Cells for Relapsed and Refractory Aggressive B Cell Non-Hodgkin Lymphoma

Comprehensive Geriatric Assessment to Predict Toxic Events in Older Patients With Non-Hodgkin Lymphoma With Imbedded Pilot Study of Pre-Phase Therapy

Mathematical Modeling to Predict the Duration of Thrombocytopenia in Neonates

Sorafenib Plus Doxorubicin in Patients With Advanced Hepatocellular Carcinoma With Disease Progression on Sorafenib

BYL719 and Letrozole in Post-Menopausal Patients With Hormone Receptor-Positive Metastatic Breast Cancer

Ask Advise Connect (AAC) Harris Heath CPRIT

DIGItal Cohort Osteoarthritis Design

Survivorship and Outcomes of Robotic-Arm Assisted Bicompartmental Arthroplasty

A Long-Term Registry of Humira® (Adalimumab) in Patients With Moderately to Severely Active Ulcerative Colitis (UC)

An Investigational Scan (MRI With Dixon Based Sequences) in Detecting Prostate Cancer

PD 0332991 and Anastrozole for Stage 2 or 3 Estrogen Receptor Positive and HER2 Negative Breast Cancer

Visualization of Asymptomatic Atherosclerotic Disease for Optimum Cardiovascular Prevention

PET/CT and Lymph Node Mapping in Finding Lymph Node Metastasis in Patients With High-Risk Endometrial Cancer

Ibrutinib in Treating Patients With Relapsed or Refractory Follicular Lymphoma

Efficacy and Safety of TORS for SCCA

Safety Study of Adding Everolimus to Adjuvant Hormone Therapy in Women With High Risk of Relapse, ER+ and HER2- Primary Breast Cancer, Free of Disease After Receiving at Least One Year of Adjuvant Hormone Therapy

French Database of Occipital Nerves Stimulation in the Treatment of Refractory Chronic Headache Disorders

A Phase I/II Study of Hypofractionated Proton Therapy for Stage II-III Non-Small Cell Lung Cancer